Njord Partners Sells SolidAl to NKT
Njord Partners, the special situations investment manager, today announces that it has agreed to sell SolidAl - Condutores Eléctricos, S.A. (“SolidAl” or the “Company”), a leading Portuguese manufacturer of power cables and supplier of integrated solutions for energy transmission and distribution, to NKT, one of the world’s leading power cable companies.
SolidAl has over 50 years of experience delivering power cables for projects across more than 40 countries. The Company, which is located in Esposende, Portugal, has 430 employees and is focused on European markets, principally France, Spain, Portugal, Ireland and the UK.
Njord Partners first invested in SolidAl in 2015, when, against the backdrop of a complex and short-term debt structure, the Company required a funding solution to provide working capital and increase the capacity of the Company’s key production plant in Esposende in Northern Portugal. Njord Partners created a solution that solved both the issue of the short-dated nature of the Company’s debt and its complex capital structure, and addressed SolidAl’s need for working capital.
Njord Partners’ became majority shareholder in 2018, and under its guidance, a new and highly experienced leadership and advisory team was introduced to strengthen capabilities across the business, resulting in a full financial restructuring and operational turnaround, the success of which was recognized by the Turnaround Management Association (TMA) in 2020 as International Company Turnaround of the Year, and is reflected in SolidAl’s profitable growth since 2018.
Since Njord Partners’ initial investment, SolidAl has experienced very strong growth, more than doubling its revenue and EBITDA and in 2023 generated revenue of approximately €150m and EBITDA of approximately €20m. NKT has acquired SolidAl for a total enterprise value of €192m, an EV/EBITDA multiple of 9.4x.
Arvid Trolle, co-founder of Njord Partners, commented: "We are proud to have supported SolidAl in its turnaround. The Company’s significant progress is testament to Francois Moufflet and his leadership team who have led the transformation of the business and were awarded Company Turnaround of the Year in recognition of their efforts. NKT is the best partner to continue SolidAl’s journey and we look forward to seeing its ongoing success."
Francois Moufflet, CEO at SolidAl, added: “Our partnership with the Njord team has been a great success. Our shared dedication to transform the business has enabled SolidAl to strengthen its position across Europe. We look forward to our partnership with the NKT team and a new growth phase for SolidAl.”
Njord Partners was advised on the transaction by Lazard (M&A), Barou Advisers (M&A), Macfarlanes (Legal) and Uría Menéndez (Legal - Portugal).
About Njord Partners
Njord Partners is a special situations investment manager and provider of long-term flexible capital solutions. Established in 2013, Njord Partners manages capital in excess of €1 billion. Investing in European middle-market companies facing complex situations, its mission is to deliver superior risk-weighted returns to investors while preserving capital. As a capital partner, Njord Partners offers flexible debt and equity solutions, actively facilitating strategic and operational enhancements within its portfolio companies to drive value.
To find out more visit: https://njordpartners.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20240620812662/en/
Contacts
Media enquiries:
via Camarco
njord@apcoworldwide.com
Jennifer Renwick +44 7928 471 013
Letaba Rimell +44 7715 530 664
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
I-care Becomes a Unicorn23.12.2025 10:45:00 CET | Press Release
I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom